Granulocyte-macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-cont (Q78138559)
Jump to navigation
Jump to search
scientific article published on 01 August 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Granulocyte-macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-cont |
scientific article published on 01 August 1999 |
Statements
Granulocyte-macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial) (English)
X Thomas
P Fenaux
H Dombret
S Delair
F Dreyfus
H Tilly
A Vekhoff
P Cony-Makhoul
V Leblond
X Troussard
C Cordonnier
T de Revel
M Simon
F Nicolini
A M Stoppa
M Janvier
D Bordessoule
P Rousselot
M Ffrench
J P Marie